In
January 2026, Bloomberg reported that Xiamen Hithium Energy Storage
Technology Co. withdrew from technology-sharing discussions with Reliance
Industries, citing Beijing’s tightening export controls on battery
technology. The implication was direct: India’s largest private company may
have been blocked from accessing crucial know-how—placing its gigafactory
ambitions in uncertainty.
Both
sides responded quickly. Reliance said it was “strongly and categorically”
maintaining its battery manufacturing plans and that its 2026 timeline
remained unchanged. Hithium, for its part, stated it had made no media
comments about any partnership talks.
What
was not denied is just as significant. Reliance did not dispute that
discussions with Hithium occurred—or that they stalled. Hithium did not reject
the possibility of technology-sharing exploration, nor the likelihood that Chinese
export controls could limit what happens next. Together, these careful
statements suggest a story that is less like a clean break and more like a
negotiation constrained by policy.
The Real Warning: Dependency Can
Be Weaponised
Even
if no formal “no” was issued, the episode highlights a structural vulnerability
India can no longer ignore.
Reliance—reported
to be seeking a license for battery cell technology—was described as
negotiating with a Chinese startup founded in 2019. That startup
reportedly generated far smaller revenues, yet held valuable chemistry
and cell-technology expertise. The gap between the firms is stark: Reliance is dozens
of times larger than its counterpart. If such a relationship is plausible,
it points to a deeper issue: India’s industrial capability in certain critical
layers of the battery value chain still has exposed seams.
And
that leads to the uncomfortable question beneath the headlines:
what happens when China does say no—explicitly and decisively?
The “Humiliation” Playbook China
Learned From Denial
This
is not a hypothetical problem. Technology denial has repeatedly shaped
great-power competition, and China’s own modern trajectory offers a recurring
pattern: embargoes and restrictions may delay progress, but they often
accelerate the creation of domestic alternatives.
Many
Western export and technology restrictions against China have unintentionally
pushed Beijing toward self-reliance. Over time, the denied areas did not
remain permanently unreachable. Instead, they became domains where China built
competitive—sometimes superior—capabilities.
Consider
the broader logic:
- Denial
creates scarcity of inputs.
- Scarcity
forces mobilised innovation.
- Innovation
reduces reliance.
- Reduced
reliance strengthens leverage in the next round of competition.
The
strategic lesson is not that denial causes instant success. It often involves
long gaps, quality compromises, and stretched timelines. But the directional
outcome has frequently been transformation: from dependence to capability, from
student to competitor.
Vulnerability, Illustrated:
Batteries Are a Strategic Layer
Now
return to batteries and Reliance.
China
reportedly tightened restrictions on lithium battery technology transfers in October
2025, requiring export permits for strategic technologies and giving
Beijing wide discretion over what can cross borders. A firm like Hithium may
want to partner with Indian players—but it operates within a regulatory system
that can shut cooperation off regardless of commercial interest.
This
is the core problem for India’s battery transition: key parts of the ecosystem
still depend on technology controlled by a strategic rival. As a result,
India’s gigafactory plans, clean-energy manufacturing ambitions, and EV-related
scaling efforts are built on an assumption that China will continue
cooperating—and that cooperation, China has no obligation to provide.
An
episode like this—real or exaggerated—should concentrate attention on one
conclusion:
India’s battery strategy needs resilience against sudden, policy-driven
disruption.
Reliance’s Accumulation Problem:
Patents Without Substitution
Reliance,
to its credit, has not been idle.
Since
2021, Reliance New Energy Solar has reportedly invested heavily in
battery-related acquisitions across multiple chemistries—aiming to build a
domestic knowledge base rather than relying entirely on imports. On paper, the
portfolio looks wide: sodium-ion, lithium iron phosphate-related assets, and
grid-storage battery research.
However,
there is a difference between owning technology rights and delivering
industrial scale. Several indicators point to a recurring challenge:
acquisitions do not automatically translate into manufacturing maturity,
supply-chain control, and repeatable commercial performance.
In
other words, the issue may not be a shortage of purchased assets. It may be a
shortage of integration—turning acquired IP into an indigenous
manufacturing pathway that is strong enough to stand in for denied foreign
inputs.
That
is why even the possibility of technology denial matters: the assets may not
yet function as full substitutes for proven production know-how.
The Jio Institute Anomaly: Money
Without Battery Depth
A
particularly striking question concerns research priorities.
Reliance
operates Jio Institute in Navi Mumbai, backed by a large financial
commitment and staffed with credible academic leadership. Yet the current
programme profile—at least as described in your text—does not include a
dedicated battery chemistry, electrochemistry, or energy-storage materials
research track.
This
creates a mismatch: substantial funds have been directed toward acquiring
battery patents from abroad, while the institution designed for deep
academic-industry research does not appear to mirror that specific technical
mission.
Reliance
has demonstrated it can support deep-tech academic partnerships (for example
through AI collaborations with top institutions). The unanswered question is
whether battery science will receive comparable institutional attention—or
whether the company will continue relying on foreign transfers while its own
internal research capacity remains underutilised.
What Government Has Done Right:
Patient Capital and the Missing Bridge
The
policy response matters, and your draft highlights an important point: the Modi
government has begun building financing infrastructure aimed at precisely
the kind of deep-technology development India needs.
The
Research, Development and Innovation (RDI) Fund, announced in Budget
2025, is described as a patient capital mechanism, with a long
investment horizon meant to reduce the “valley of death” risk that kills
promising innovations before scale.
The
logic is sound:
- India’s
business contribution to R&D is often lower than global norms.
- Corporate
spending on in-house research remains comparatively limited.
- Traditional
financing frequently cannot tolerate long timelines and early failure.
The
fund’s structure—co-investment requirements, incentives for fund managers, and
a Technology Readiness focus—could help close the gap between prototypes and
commercial execution.
But
financing alone is not enough. The final responsibility is whether India’s
corporate leaders commit to using this capital aggressively—building the
capabilities that reduce dependence rather than merely postponing it.
The Missing Middle: Little
Giants and India’s MSME Bottleneck
Still,
the RDI Fund addresses only one part of a broader ecosystem problem.
India’s
battery transition requires not only large champions and conglomerates, but
also a thick layer of specialised mid-tier and small firms—suppliers that can
iterate materials, manufacturing processes, components, and quality systems.
China’s
approach through “Little Giants” is often cited as a model: a tiered
recognition and support system that identifies capable firms, pushes them
toward specialisation, and integrates them into strategic value chains.
By
contrast, India’s MSME landscape—though huge in number—leans heavily toward
microenterprises. That is not automatically bad, but it becomes a structural
constraint when regulations, credit availability, and compliance costs
discourage growth into specialised manufacturing roles.
If
India wants batteries built domestically rather than assembled from imported
cores, it needs a stronger “middle layer”—the type of specialised firms that
can become globally competitive in niche segments.
From Vulnerability to
Determination: What India Should Do Now
The
Reliance–Hithium episode—whatever its exact contours—offers a useful service:
it forces a discussion India has long tried to postpone. India’s clean-energy
transition depends on technology that could be constrained or withdrawn. That
is a strategic risk, not a PR problem.
This
is where the historical comparison becomes practical. China’s technological
sovereignty was, at least in part, accelerated by denial. India does not need
to wait for its own “unforgettable humiliation.” A near-miss—or even a credible
threat—should be enough to create urgency.
What
should follow is clear:
- strengthen
battery R&D depth, not just patent ownership,
- convert
corporate investment into manufacturing substitution capability,
- use
public patient capital effectively,
- build
a specialised manufacturing ecosystem through an approach like “Little
Giants,”
- and
ensure corporate champions match government ambition with execution.
The
question raised by Hithium is not simply “Did China say no?”
It is: “What will India do when China does?”
The
answer will determine whether India remains a technology taker—or becomes,
finally, a technology maker.